Head and Neck Cancer

Head & Neck Cancer

Head and Neck Cancer (HNC) are the seventh most common cancers globally, and the incidence is increasing in Canada. HNC are a group of cancers in the head and neck and include cancer in the mouth or oral cavity (lips, tongue, gums), the throat (pharynx), the voice box (larynx), nasal/sinus cavity, and salivary glands. The K2I Lab, in partnership with the Ohlson Research Initiative, aims to improve the clinical effectiveness of HNC care.

Published Work

Exploring transitions in care among patients with head and neck cancer: a multimethod study
The Association of Ethnicity and Oncologic Outcomes for Oral Cavity Squamous Cell Carcinoma (OSCC)
Multiphasic exercise prehabilitation for patients undergoing surgery for head and neck cancer: a hybrid effectiveness-implementation study protocol
From Pathways to Practice: Impact of Implementing Mobilization Recommendations in Head and Neck Cancer Surgery with Free Flap Reconstruction
Impact of Early Mobilization on Recovery after Major Head and Neck Surgery with Free Flap Reconstruction
Preoperative hemoglobin and perioperative blood transfusion in major head and neck surgery: a systematic review and meta-analysis
Designing and integrating a quality management program for patients undergoing head and neck resection with free-flap reconstruction
The impact of a quality management program for patients undergoing head and neck resection with free-flap reconstruction: longitudinal study examining sustainability

The Ohlson Research Initiative (ORI)

The K2I Lab works in partnership with the Ohlson Research Initiative (ORI), a clinical effectiveness research program that creates new knowledge focused on patients with head and neck cancer.

Dr. Sauro is the Ohlson Professor in Head and Neck Cancer Health Services Research.

Learn more about ORI